Acurx Pharmaceuticals, Inc. ACXP 深 沪
已收盘 05-08 16:00:00 美东时间
2.09
-0.030
-1.42%
华盛通- 最 高2.12
- 今 开2.12
- 成交量 6.04万股
- 最 低 2.03
- 昨 收 2.12
- 总市值 769.14万
- 52周最高 21.00
- 市盈率 静 --
- 换手率 1.64%
- 52周最低 1.3259
- 委 比 37.93%
- 总股本 368.01万
- 历史最高 176.40
- 量 比 0.57
- 振 幅 4.25%
- 历史最低 1.3259
- 每 手 1
- 风险率 2.58%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Acurx Pharmaceuticals to Present at the Alliance Global Partners (A.G.P) Healthcare Company Showcase
STATEN ISLAND, N.Y., April 29, 2026 /PRNewswire/ -- Acurx Pharmaceuticals (Nasdaq: ACXP) (Acurx or the Company), a fully-integrated biopharmaceutical company developing a new class of antibi...
04-29 20:00
Acurx Pharmaceuticals Announces $7.1M Registered Direct Offering Of 825,085 Shares At $3.03/Share
$2.5 million upfront with up to an additional $4.6 million of potential aggregate gross proceeds upon the exercise in full of short-term warrants
04-16 20:10
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers Immutep (NASDAQ:IMMP) shares rose 135.4% to $0.74 during Wednesday's p...
04-15 20:05
Acurx Pharma Granted Korean Patent For DNA Polymerase IIIC Inhibitors Including Compositions‑Of‑Matter, Methods Of Use, And Pharmaceutical Compositions
Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of small molecule antibiotics for difficult‑to‑treat bacterial infections, today
03-30 19:17
Korean Patent Office Grants Acurx Pharmaceuticals New Patent for DNA Polymerase IIIC Inhibitors
STATEN ISLAND, N.Y., March 30, 2026 /PRNewswire/ -- Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of sm...
03-30 19:01
美股夜盘 | Paranovus Entertainment Technology Ltd. - Class A Ordinary Shares涨81.10%，网络齿轮通信涨16.41%
Paranovus Entertainment Technology Ltd. - Class A Ordinary Shares涨81.10%；网络齿轮通信涨16.41%；BioCryst制药涨14.18%
03-24 15:02
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers Serina Therapeutics (AMEX:SER) shares moved upwards by 94.5% to $2.49 d...
03-20 01:05
Earnings Scheduled For March 13, 2026
Companies Reporting Before The Bell • Douglas Elliman (NYSE:DOUG) is likely to ...
03-13 19:11
Acurx Pharmaceuticals Q4 EPS $(0.73) Beats $(1.65) Estimate
Acurx Pharmaceuticals (NASDAQ:ACXP) reported quarterly losses of $(0.73) per share which beat the analyst consensus estimate of $(1.65) by 55.62 percent. This is a 78.53 percent increase over losses of $(3.40) per share
03-13 19:01
Why Is Acurx Pharmaceuticals Stock Up Over 105% Today?
Acurx Pharmaceuticals Inc shares are trading sharply higher Wednesday afternoon despite a lack of company-specific news during the session.
03-12 02:45
